Simple spectrophotometric methods for the simultaneous determination of antipyrine and benzocaine

Antipyrine and benzocaine are formulated together for the treatment of ear inflammation and to relieve pain. Four spectrophotometric methods were developed for the simultaneous determination of antipyrine (AN) and benzocaine (BE) in their combined dosage form. Method A depends on applying dual wavel...

Full description

Bibliographic Details
Main Author: Hanan A. Merey
Format: Article
Language:English
Published: Faculty of Pharmacy, Cairo University 2016-12-01
Series:Bulletin of Faculty of Pharmacy Cairo University
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1110093116300205
_version_ 1797971092474691584
author Hanan A. Merey
author_facet Hanan A. Merey
author_sort Hanan A. Merey
collection DOAJ
description Antipyrine and benzocaine are formulated together for the treatment of ear inflammation and to relieve pain. Four spectrophotometric methods were developed for the simultaneous determination of antipyrine (AN) and benzocaine (BE) in their combined dosage form. Method A depends on applying dual wavelength method where antipyrine was determined by measuring the absorbance at 254.1 and 309.1 nm (corresponding to zero difference of benzocaine), while the absorbance difference at 230.1 and 263.5 nm (corresponding to zero difference of antipyrine) was selected for benzocaine determination in the laboratory prepared spectrum. Method B depends on measuring the peak amplitude of first derivative at 305 nm for calculating benzocaine concentration then the total concentration of both drugs was determined using isoabsorptive point at 257.4 nm (antipyrine concentration was then calculated by subtraction). Method C is based on measuring the peak difference of the ratio spectra at Δp (239.1–285 nm) and Δp (301.4–250 nm) for the determination of antipyrine and benzocaine, respectively. Method D depends on measuring peak to peak amplitude of the first derivative of ratio spectra at (234.5 + 244.2 nm) and peak amplitude at 295.5 nm for the determination of antipyrine and benzocaine, respectively. The proposed methods were validated and applied for the analysis of antipyrine and benzocaine in their laboratory prepared mixtures and pharmaceutical formulation. Statistical comparison between the results of the proposed methods and those of the reported methods showed no significant difference.
first_indexed 2024-04-11T03:27:15Z
format Article
id doaj.art-aee0ab31091e4724b73e661cf11f549d
institution Directory Open Access Journal
issn 1110-0931
language English
last_indexed 2024-04-11T03:27:15Z
publishDate 2016-12-01
publisher Faculty of Pharmacy, Cairo University
record_format Article
series Bulletin of Faculty of Pharmacy Cairo University
spelling doaj.art-aee0ab31091e4724b73e661cf11f549d2023-01-02T07:16:08ZengFaculty of Pharmacy, Cairo UniversityBulletin of Faculty of Pharmacy Cairo University1110-09312016-12-0154218118910.1016/j.bfopcu.2016.05.003Simple spectrophotometric methods for the simultaneous determination of antipyrine and benzocaineHanan A. MereyAntipyrine and benzocaine are formulated together for the treatment of ear inflammation and to relieve pain. Four spectrophotometric methods were developed for the simultaneous determination of antipyrine (AN) and benzocaine (BE) in their combined dosage form. Method A depends on applying dual wavelength method where antipyrine was determined by measuring the absorbance at 254.1 and 309.1 nm (corresponding to zero difference of benzocaine), while the absorbance difference at 230.1 and 263.5 nm (corresponding to zero difference of antipyrine) was selected for benzocaine determination in the laboratory prepared spectrum. Method B depends on measuring the peak amplitude of first derivative at 305 nm for calculating benzocaine concentration then the total concentration of both drugs was determined using isoabsorptive point at 257.4 nm (antipyrine concentration was then calculated by subtraction). Method C is based on measuring the peak difference of the ratio spectra at Δp (239.1–285 nm) and Δp (301.4–250 nm) for the determination of antipyrine and benzocaine, respectively. Method D depends on measuring peak to peak amplitude of the first derivative of ratio spectra at (234.5 + 244.2 nm) and peak amplitude at 295.5 nm for the determination of antipyrine and benzocaine, respectively. The proposed methods were validated and applied for the analysis of antipyrine and benzocaine in their laboratory prepared mixtures and pharmaceutical formulation. Statistical comparison between the results of the proposed methods and those of the reported methods showed no significant difference.http://www.sciencedirect.com/science/article/pii/S1110093116300205AntipyrinePhenazoneBezocaineDual wave lengthIsoabsorptive pointDifferent spectrophotometric method
spellingShingle Hanan A. Merey
Simple spectrophotometric methods for the simultaneous determination of antipyrine and benzocaine
Bulletin of Faculty of Pharmacy Cairo University
Antipyrine
Phenazone
Bezocaine
Dual wave length
Isoabsorptive point
Different spectrophotometric method
title Simple spectrophotometric methods for the simultaneous determination of antipyrine and benzocaine
title_full Simple spectrophotometric methods for the simultaneous determination of antipyrine and benzocaine
title_fullStr Simple spectrophotometric methods for the simultaneous determination of antipyrine and benzocaine
title_full_unstemmed Simple spectrophotometric methods for the simultaneous determination of antipyrine and benzocaine
title_short Simple spectrophotometric methods for the simultaneous determination of antipyrine and benzocaine
title_sort simple spectrophotometric methods for the simultaneous determination of antipyrine and benzocaine
topic Antipyrine
Phenazone
Bezocaine
Dual wave length
Isoabsorptive point
Different spectrophotometric method
url http://www.sciencedirect.com/science/article/pii/S1110093116300205
work_keys_str_mv AT hananamerey simplespectrophotometricmethodsforthesimultaneousdeterminationofantipyrineandbenzocaine